Navigation Links
John Theurer Cancer Center presents significant blood cancer research at 2012 ASCO Annual Meeting
Date:5/29/2012

2 1:00pm-5:00pm highlight this one more
  • 8011- Stringent complete response in patients with newly diagnosed multiple myeloma (NDMM) treated with carfilzomib, lenalidomide, and dexamethasone, David H. Vesole, MD, PhD et all. Oral Session: June 3, 2012 8:00am-11:00pm
  • 8016 - Pomalidomide with or without low-dose dexamethasone in patients with relapsed/refractory multiple myeloma: Outcomes in patients refractory to lenalidomide and/or bortezomib, David S. Siegel, MD, PhD et all. Oral Session: June 3, 2012 8:00am-11:00pm
  • 8035 - Response rates to single-agent carfilzomib in patients refractory or intolerant to both bortezomib and immunomodulators in trial PX-171-003-A1, David S. Siegel, MD, PhD et all. Poster Session: June 2, 2012 8:00am-12:00pm
  • TPS6636 - A single-arm, open-label, multicenter study of complete molecular response in patients with newly diagnosed Philadelphia chromosomepositive chronic myeloid leukemia in chronic phase treated with nilotinib, Stuart Goldberg, MD et all. Poster Session: June 4, 2012 1:15pm-5:15pm

    "Our research presented at this conference would not have been possible without the patients who participate in our clinical trials," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., chief innovation officer, professor and vice president of cancer services, John Theurer Cancer Center. "We are thankful to our patients, our researchers, and our partnering institutions who help us bring novel therapies and improved regimens for cancer patients."


    '/>"/>


  • Contact: Amy Leahing
    aleahing@p4strategy.com
    John Theurer Cancer Center
    Source:Eurekalert

    Page: 1 2

    Related biology news :

    1. John Theurer Cancer Center BMT researchers highlight the importance of social support
    2. John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting
    3. National experts from the John Theurer Cancer Center will present 31 studies at the 2011 ASH Meeting
    4. Breast cancer treatment resistance linked to signaling pathway
    5. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
    6. The dietary supplement genistein can undermine breast cancer treatment
    7. Saliva proteins could help detection of oral cancer
    8. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
    9. Breakthrough optical technology to assess colon cancer risk, accuracy
    10. Breast cancer cells recycle to escape death by hormonal therapy
    11. Nanodiamond drug device could transform cancer treatment
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2014)... climate change on the world,s animal and plant ... to a new paper by a research team ... and other organizations. The authors claim that most ... when it comes to climate change. , ... on the "direct" threats of changing temperatures and ...
    (Date:7/30/2014)... San Antonio Life Sciences Institute (SALSI), a joint venture ... and The University of Texas Health Science Center at ... Initiative Pilot Program. The winners, Emily Boice from UTSA ... receive $25,000 for their project titled, "Novel engineered ferritins ... environment." , Boice and Huang,s research is focused on ...
    (Date:7/30/2014)... University associate professor Andrew S. Mount, performed cutting-edge research ... for novel anti-fouling paint for ships and boats and ... The team,s findings, published in Nature Communications ... that attaches to a wide variety of surfaces using ... an underwater heavy-duty adhesive. , "In previous research, we ...
    Breaking Biology News(10 mins):Conservation scientists asking wrong questions on climate change impacts on wildlife 2Study: Marine pest provides advances in maritime anti-fouling and biomedicine 2
    ... hockey goalie, and two opposing players are breaking in alone ... of the linesman skating in on your left, but pay ... the two approaching players. As the action unfolds, how is ... splitting your focus of attention into multiple "spotlights?" Are you ...
    ... by researchers at Columbia University,s Mailman School of Public ... quality regulations proposed or recently adopted by the U.S. ... standards for reducing dangerous emissions of mercury and other ... implementing the new regulations is estimated to be about ...
    ... , The National Institute of Standards and Technology (NIST) ... carbon nanotube soot. Distantly related to the soot in ... is the primary industrial source of single-wall carbon nanotubes, ... NIST material offers companies and researchers a badly needed ...
    Cached Biology News:How do we split our attention? 2New EPA air quality rules outweigh costs and provide major health and environmental benefits 2NIST releases first certified reference material for single-wall carbon nanotubes 2NIST releases first certified reference material for single-wall carbon nanotubes 3
    (Date:7/30/2014)... 30, 2014  AtheroNova Inc. (OTCBB: AHRO), a ... of compounds to safely regress atherosclerotic plaque and ... its partner, CardioNova, has accomplished first dosing of ... AtheroNova,s lead compound, AHRO-001.  This Phase 1b trial ... 1 safety trial completed in February 2014, in ...
    (Date:7/30/2014)... San Diego, CA (PRWEB) July 30, 2014 ... Pipette.com announced their weighing boat special – ... Get 1 free. This promotion will benefit lab technicians ... their work. Weighing boats are ideal for multiple applications ... Pipette.com offers a variety of choices including diamond-shaped, hexagonal, ...
    (Date:7/29/2014)... of significant technological challenges in their quest to ... for the James Webb Space Telescope. , The ... scientist at NASA,s Goddard Space Flight Center in ... arrays that is, those activated by applying ... the current technology,s magnetically activated arrays. This advance ...
    (Date:7/29/2014)... 2014) Tough, ultralight foam of atom-thick sheets can ... chemical process invented at Rice University. , In ... nanoscale building, with floors and walls that reinforce each ... materials: floors and walls of graphene oxide that self-assemble ... , The researchers say the foam could find use ...
    Breaking Biology Technology:AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 4Weighing Boat Promotion Now Available at Pipette.com, Major Pipette Distributor 2Revolutionary microshutter technology hurdles significant challenges 2Revolutionary microshutter technology hurdles significant challenges 3Revolutionary microshutter technology hurdles significant challenges 4Tough foam from tiny sheets 2
    ... on Thursday, October 25, 2007 at ... ... Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on ... treatment of life-threatening,diseases, including diabetes and cancer, today announced its results ...
    ... Biosciences, Inc. Presents Initial Data on RDEA119 at ... and Cancer Therapeutics -, SAN FRANCISCO, Oct. ... a company focused on the discovery and development ... cancer and,inflammatory diseases, today presented preclinical data on ...
    ... Md., Oct. 24 MedImmune, Inc. announced,today that ... recognized the company for its employees, exceptional commitment ... Volunteer Award,for a large business. "As the ... as an outstanding corporate citizen whose employees strive ...
    Cached Biology Technology:Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 4Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 5Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 6New Oral MEK Inhibitor, RDEA119, Shows Favorable Anti-Tumor Properties 2New Oral MEK Inhibitor, RDEA119, Shows Favorable Anti-Tumor Properties 3New Oral MEK Inhibitor, RDEA119, Shows Favorable Anti-Tumor Properties 4
    ...
    ...
    with GlutaMAXIL-glutamine...
    ... PURIFIED GOAT ANTI-MOUSE IgG+IgA+IgM ... conjugated with highly purified ... The antibody has been ... rat, fetal bovine, horse, ...
    Biology Products: